Ru-Xing Wang Selected Research

Ru-Xing Wang Research Topics

Disease

9	Atrial Fibrillation 06/2022 - 11/2013
5	Heart Failure 01/2021 - 06/2009
4	Diabetes Mellitus 01/2022 - 04/2010
3	Fibrosis (Cirrhosis) 01/2022 - 01/2020
3	Cardiac Arrhythmias (Arrythmia) 01/2022 - 02/2011
2	Left Ventricular Dysfunction 01/2022 - 11/2013
2	Chronic Renal Insufficiency 01/2021 - 05/2015
2	Coronary Artery Disease (Coronary Atherosclerosis) 03/2019 - 02/2013
2	Diabetes Complications 01/2019 - 01/2018
2	Sudden Death 05/2013 - 02/2011
1	Ventricular Tachycardia 06/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Hyperglycemia 01/2022
1	Atrial Remodeling 12/2021
1	Inflammation (Inflammations) 11/2021
1	Hypotension (Low Blood Pressure) 08/2021
1	Infarction (Infarctions) 01/2021
1	Myocardial Infarction 01/2021
1	Renal Insufficiency (Renal Failure) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Neoplasms (Cancer) 01/2020
1	Starvation 01/2020
1	Reperfusion Injury 01/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020
1	Bradycardia 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Sepsis (Septicemia) 12/2015
1	Multiple Sclerosis 07/2014
1	Thrombosis (Thrombus) 11/2013
1	Sick Sinus Syndrome 11/2013
1	Coronary Disease (Coronary Heart Disease) 02/2013
1	Dyspnea (Shortness of Breath) 06/2009

Drug/Important Bio-Agent (IBA)

5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2019
3	Therapeutic UsesIBA 01/2020 - 12/2015
3	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2020 - 04/2010
2	Anti-Arrhythmia AgentsIBA 06/2022 - 08/2021
2	InflammasomesIBA 01/2022 - 02/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2010 - 06/2009
1	Moricizine (Moracizine)FDA Link 06/2022
1	SodiumIBA 06/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2022
1	Ethanol (Ethyl Alcohol)IBA 01/2022
1	Calcium Gluconate (CBG)IBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	LipidsIBA 01/2022
1	NucleotidesIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2022
1	Biological ProductsIBA 12/2021
1	MicroRNAs (MicroRNA)IBA 11/2021
1	Adrenergic Agents (Adrenergic Drugs)IBA 02/2020
1	Calcium Channels (Calcium Channel)IBA 02/2020
1	DiosgeninIBA 01/2020
1	iberiotoxinIBA 01/2020
1	QuercetinIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	InterleukinsIBA 03/2019
1	Interleukin-8 (Interleukin 8)IBA 03/2019
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2018
1	Beclin-1IBA 12/2015
1	Small Interfering RNA (siRNA)IBA 12/2015
1	Antihypertensive Agents (Antihypertensives)IBA 05/2015
1	Interleukin-6 (Interleukin 6)IBA 11/2013
1	Dichlorodiphenyldichloroethane (DDD)IBA 11/2013
1	ConnexinsIBA 02/2013
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 02/2011
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2011
1	Angiotensin IIIBA 04/2010
1	Natriuretic PeptidesIBA 06/2009

Therapy/Procedure

6	Therapeutics 08/2021 - 06/2009
4	Catheter Ablation 01/2022 - 05/2013
2	Cardiac Resynchronization Therapy 01/2021 - 02/2011
1	Radiotherapy 01/2021
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Defibrillators (Defibrillator) 01/2021
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020
1	Stents 02/2013
1	Patient Readmission 06/2009